Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial
- PMID: 20485304
- PMCID: PMC2906750
- DOI: 10.1038/ejcn.2010.65
Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial
Abstract
Background: To evaluate whether a fermented dairy drink containing the probiotic strain Lactobacillus casei DN-114 001 could reduce the incidence of common infectious diseases (CIDs) and the change of behavior because of illness in children.
Subjects/methods: We conducted a double-blinded, randomized, placebo-controlled allocation concealment clinical trial in the Washington, DC metropolitan area. Participants were 638 children 3-6 years old in daycare/schools. The intervention was a fermented dairy drink containing a specific probiotic strain or matching placebo with no live cultures for 90 consecutive days. Two primary outcomes were assessed: incidence of CIDs and change of behavior because of illness (both assessed by parental report).
Results: The rate of change of behavior because of illness was similar among active and control groups. However, the incidence rate for CIDs in the active group (0.0782) is 19% lower than that of the control group (0.0986) (incidence rate ratio=0.81, 95% CI: 0.65, 099) P=0.046.
Conclusions: Daily intake of a fermented dairy drink containing the probiotic strain L. casei DN-114 001 showed some promise in reducing overall incidence of illness, but was primarily driven by gastrointestinal infections and there were no differences in change of behavior.
Figures
Similar articles
-
Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial.J Am Coll Nutr. 2010 Oct;29(5):455-68. doi: 10.1080/07315724.2010.10719882. J Am Coll Nutr. 2010. PMID: 21504972 Clinical Trial.
-
Effects of a Fermented Dairy Drink Containing Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 (Lactobacillus casei CNCM I-1518) and the Standard Yogurt Cultures on the Incidence, Duration, and Severity of Common Infectious Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Nutrients. 2020 Nov 10;12(11):3443. doi: 10.3390/nu12113443. Nutrients. 2020. PMID: 33182682 Free PMC article.
-
Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial.Br J Nutr. 2010 Jan;103(1):58-68. doi: 10.1017/S0007114509991395. Epub 2009 Sep 14. Br J Nutr. 2010. PMID: 19747410 Clinical Trial.
-
Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study.J Nutr Health Aging. 2003;7(2):75-7. J Nutr Health Aging. 2003. PMID: 12679825 Clinical Trial.
-
Effect of probiotic fermented dairy products on incidence of respiratory tract infections: a systematic review and meta-analysis of randomized clinical trials.Nutr J. 2021 Jun 28;20(1):61. doi: 10.1186/s12937-021-00718-0. Nutr J. 2021. PMID: 34183001 Free PMC article.
Cited by
-
Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study.Eur J Clin Nutr. 2015 Mar;69(3):373-9. doi: 10.1038/ejcn.2014.174. Epub 2014 Sep 10. Eur J Clin Nutr. 2015. PMID: 25205320 Free PMC article. Clinical Trial.
-
Preventive Effect of Cow's Milk Fermented with Lactobacillus paracasei CBA L74 on Common Infectious Diseases in Children: A Multicenter Randomized Controlled Trial.Nutrients. 2017 Jun 27;9(7):669. doi: 10.3390/nu9070669. Nutrients. 2017. PMID: 28654019 Free PMC article. Clinical Trial.
-
Overview of anti-viral effects of probiotics via immune cells in pre-, mid- and post-SARS-CoV2 era.Front Immunol. 2023 Dec 5;14:1280680. doi: 10.3389/fimmu.2023.1280680. eCollection 2023. Front Immunol. 2023. PMID: 38116008 Free PMC article. Review.
-
Functional foods as a formulation ingredients in beverages: technological advancements and constraints.Bioengineered. 2021 Dec;12(2):11055-11075. doi: 10.1080/21655979.2021.2005992. Bioengineered. 2021. PMID: 34783642 Free PMC article. Review.
-
Postbiotics for Preventing and Treating Common Infectious Diseases in Children: A Systematic Review.Nutrients. 2020 Jan 31;12(2):389. doi: 10.3390/nu12020389. Nutrients. 2020. PMID: 32024037 Free PMC article.
References
-
- Agarwal KN, Bhasin SK. Feasibility studies to control acute diarrhoea in children by feeding fermented milk preparations Actimel and Indian Dahi. Eur J Clin Nutr. 2002;56 (Suppl 4:S56–S59. - PubMed
-
- Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Selected commensal-related bacteria and toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology. 2009;128:e523–e531. - PMC - PubMed
-
- Cordell RL, MacDonald JK, Solomon SL, Jackson LA, Boase J. Illnesses and absence due to illness among children attending child care facilities in Seattle-King County, Washington. Pediatrics. 1997;100:850–855. - PubMed
-
- Dales R, Cakmak S, Brand K, Judek S. Respiratory illness in children attending daycare. Pediatric Pulmonology. 2004;38:6409. - PubMed
-
- de Moreno de LeBlanc A, Chaves S, Carmuega E, Weill R, Antoine J, Perdigon G. Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages. Immunobiology. 2008;213:97–108. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical